# Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP

> **NCT03622424** · NA · COMPLETED · sponsor: **Gelesis, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Overweight and Obesity
- PreDiabetes
- Type2 Diabetes

## Interventions

- **DEVICE:** Gelesis200
- **DEVICE:** Placebo
- **DEVICE:** Gelesis200 and Placebo

## Key facts

- **NCT ID:** NCT03622424
- **Lead sponsor:** Gelesis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-22
- **Primary completion:** 2019-11-19
- **Final completion:** 2019-12-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03622424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03622424, "Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03622424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*